New implant fights sarcoma recurrence in early trial
Disease control
Completed
This early-stage trial tested a new membrane placed during surgery to deliver chemotherapy directly to the tumor site in 21 adults with recurrent or advanced retroperitoneal sarcoma. The goal was to find a safe dose and see if it could delay cancer return. Results are still being…
Phase: PHASE1 • Sponsor: CEBIOTEX • Aim: Disease control
Last updated May 15, 2026 11:57 UTC